Vaccines

Jennifer Walsh, DNP, CPNP, CNE talks about the reasons for the sudden surge in measles cases in the United States, what clinicians can do to make their patients aware of the increase, and the potential...

The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...

Are there benefits to vaccinating women who are pregnant with a vaccine that prevents respiratory syncytial virus (RSV)-related illness in newborns? A new study examined this topic.

Sachiko Ozawa, PhD, MHS—the lead author of a new review that aimed to define hard-to-reach and hard-to-vaccinate populations—answers our questions about her latest review and about vaccine hesitancy.

Paul Van Buynder, from Griffith University in Queensland, Australia, answers our questions about the uptake of vaccination in pregnant women, a topic he will also speak about at the 13th Vaccine Congress. ...

Adwoa Bentsi-Enchill, a medical epidemiologist with the Department of Immunization Vaccines and Biologicals at WHO, answers our questions about WHO’s latest update on global typhoid vaccination.

Buddy Creech, MD, MPH, answers our questions about the importance of vaccine safety as a response to vaccine hesitancy, and what that means for public health.

Results of a recent survey showed that Meningitis B vaccination is under recommended by family practitioners and pediatricians. So, we asked Dr Sarah Mbaeyi from the CDC to clear the air.

Sarah Gilbert from the University of Oxford answers our questions about her research on an influenza vaccine that targets cellular immunity for adults aged 65 years and older.